[ad_1] Tianda Pharmaceutical (00455) announced that it has finalized the acquisition of the entire share capital of Zhuhai Tonghui Pharmaceutical through its wholly-owned indirect subsidiary, RMB 2,428 million (or about 3 million …
Read More »The Blood Times | EVA New Theatrical Edition Completes News expected to be released in 2020
[ad_1] <! – text ad placeholder -> from <! – Huang Yangda – Photographed at the Second Session of the Advisory Committee on NOC Discrimination Regulations Department of the Blood Publishing -> …
Read More »